Nobel Prize winner's cancer miracle

[Guest guest]

1. Dr. V. Schally is a 1977 Nobel Prize winner in Medicine.

2. Doxorubicin (DOX), also known as Adriamycin, is the most popular

" traditional " cancer medicine.

3. In 1996, Dr. Schally invented 2-pyrrolinodoxorubicin which he claims is

" 500-1000 times more potent " than DOX.

4. In 1997, he reported on the results he obtained by subjecting " human cancer

cell lines "

to the combination of 2-pyrrolinodoxorubicin and TAC

(Thiazolidine-4-carboxylic acid);

Dr. Schally designated this combination 'AN-257'.

5. I urge everyone to look at the results; the complete report appears on the

Internet;

Medline, www.ncbi.nlm.nih.gov/pubmed , 9012839.

6. Refer to Table 3. and divide the DOX numbers by the AN-257 numbers, and you

will see

how many " times higher " AN-257 was than DOX in causing the " Inhibition of

growth "

upon these " human cancer cell lines " -

a. Pancreatic (570/1.7) = 335

b. SCLC, Small Cell Lung Cancer (580/0.35) = 1657

c. Prostate (1500/6.7) = 224

d. Gastric, Stomach (1800/2.1) = 857.

Was the cure for cancer reported in 1997?

S. , The Cure for Cancer? , http://cures for cancer.ws/tac-cure.htm